Back to search
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Gastric Mucosa-Associated Lymphoid Tissue Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Gastric Mucosa-Associated Lymphoid Tissue Lymphoma trials you may qualify forThis first-in-human (FIH) trial is designed to assess the safety, feasibility and preliminary efficacy of a single intravenous (IV) dose of SynKIR-310 administe…
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or rec…
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial…
This trial studies the effectivity of low-dose radiation therapy with 10x2Gy for the treatment of patients with stage I-II stomach or duodenal Lymphoma (Margina…
The goal of this observational study is to establish clinical data and tissue repository in patients with gastric MALT lymphoma and controls. Participants will…
Describe the efficacy and safety of Orelabrutinib in the treatment of HP-positive gastric MALT lymphoma
This trial studies how well ultra low-dose radiation therapy works in treating patients with stage I-IV stomach mucosa-associated lymphoid tissue (MALT) lymphom…
We hypothesized that a proportion of patients with localized Helicobacter pylori-negative gastric MALT lymphoma may well respond to frontline Helicobacter pylor…